Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions: a Randomized Controlled Trial Evaluating the Efficacy of Perilesional Biopsy in Prostate Cancer Diagnosis

NCT06841211 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06841211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06841211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions: a Randomized Controlled Trial Evaluating the Efficacy of Perilesional Biopsy in Prostate Cancer Diagnosis
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2025
Completion date
December 31, 2026
Enrollment
572 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer